Panel Discussion: Ensuring High-Quality, Diverse Data Inputs & Regulatory Alignment for Robust AI in Digital Pathology
Time: 1:40 pm
day: Conference Day One
Details:
- How do quality and diversity of biospecimens directly impact the robustness, reproducibility, and clinical relevance of AI models in digital pathology?
- How can the industry navigate evolving regulatory requirements around data quality, consent, and diversity to ensure AI tools meet compliance and accelerate approvals?
- How can trusted data partnerships help build sustainable reference sets and enable continuous validation to future-proof AI and digital pathology solutions?
Speakers:
